Clinical trial
The Optimal Sequential Therapy After Long Term Denosumab Treatment
NCT05091099 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimal Sequential Therapy After Long Term Denosumab Treatment
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 10, 2022
- Completion date
- November 14, 2025
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.